The use of non-invasive respiratory assistance to facilitate bronchofiberoscopy performance in patients with hypoxemic (type one) respiratory failure - Study protocol

IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Aleksandra Oraczewska , Szczepan Cofta , Adam Warcholiński , Ewa Trejnowska , Grzegorz Brożek , Andrzej Swinarew , Daiana Stolz , Raffaele Scala , Adam Barczyk , Szymon Skoczyński
{"title":"The use of non-invasive respiratory assistance to facilitate bronchofiberoscopy performance in patients with hypoxemic (type one) respiratory failure - Study protocol","authors":"Aleksandra Oraczewska ,&nbsp;Szczepan Cofta ,&nbsp;Adam Warcholiński ,&nbsp;Ewa Trejnowska ,&nbsp;Grzegorz Brożek ,&nbsp;Andrzej Swinarew ,&nbsp;Daiana Stolz ,&nbsp;Raffaele Scala ,&nbsp;Adam Barczyk ,&nbsp;Szymon Skoczyński","doi":"10.1016/j.advms.2023.10.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Bronchofiberoscopy (FOB) is a procedure routinely performed for: lung cancer, obstruction, interstitial diseases, foreign bodies’ removal, airway clearance, and hemoptysis. It causes acute airway narrowing leading to respiratory and cardiovascular stress. Due to increasing number of ill patients with respiratory failure (RF), conventional oxygen therapy (COT) is frequently insufficient to assure accurate oxygenation and prevent RF in patients requiring FOB. In this clinical scenario, patients may be intubated and supported with invasive mechanical ventilation (IMV) with the specific aim of allowing a safe FOB. However, this invasive strategy is associated with an increased risk of IMV-associated complications.</p></div><div><h3>Materials and methods</h3><p>Our study is a planned prospective multicenter three-arm randomized controlled trial (RCT). The target number of 300 patients was calculated based on the intubation risk in RF patients, which is 0.2–2%. The patients will be assigned to each arm based on Horowitz index. In each arm, the patients will be randomly assigned to one out of two dedicated respiratory support methods in each group i.e. COT/high flow nasal cannula (HFNC), HFNC/non-invasive ventilation (NIV) and NIV/IMV. In the manuscript the current state of art in the area of respiratory support is discussed. We have underlined knowledge gaps in medical evidence which we are planning to reveal with our results.</p></div><div><h3>Results</h3><p>The results of our study are clinically crucial, because they address current gaps concerning COT/HFNC/NIV/IMV.</p></div><div><h3>Conclusion</h3><p>The expected findings of this study would allow for careful selection of respiratory support method to safely perform FOB in patients with hypoxemic RF.</p></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"68 2","pages":"Pages 474-481"},"PeriodicalIF":2.5000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1896112623000512/pdfft?md5=4d912ec83dfc85bc306489805ad0ac98&pid=1-s2.0-S1896112623000512-main.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in medical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1896112623000512","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose

Bronchofiberoscopy (FOB) is a procedure routinely performed for: lung cancer, obstruction, interstitial diseases, foreign bodies’ removal, airway clearance, and hemoptysis. It causes acute airway narrowing leading to respiratory and cardiovascular stress. Due to increasing number of ill patients with respiratory failure (RF), conventional oxygen therapy (COT) is frequently insufficient to assure accurate oxygenation and prevent RF in patients requiring FOB. In this clinical scenario, patients may be intubated and supported with invasive mechanical ventilation (IMV) with the specific aim of allowing a safe FOB. However, this invasive strategy is associated with an increased risk of IMV-associated complications.

Materials and methods

Our study is a planned prospective multicenter three-arm randomized controlled trial (RCT). The target number of 300 patients was calculated based on the intubation risk in RF patients, which is 0.2–2%. The patients will be assigned to each arm based on Horowitz index. In each arm, the patients will be randomly assigned to one out of two dedicated respiratory support methods in each group i.e. COT/high flow nasal cannula (HFNC), HFNC/non-invasive ventilation (NIV) and NIV/IMV. In the manuscript the current state of art in the area of respiratory support is discussed. We have underlined knowledge gaps in medical evidence which we are planning to reveal with our results.

Results

The results of our study are clinically crucial, because they address current gaps concerning COT/HFNC/NIV/IMV.

Conclusion

The expected findings of this study would allow for careful selection of respiratory support method to safely perform FOB in patients with hypoxemic RF.

在低氧血症(一型)呼吸衰竭患者中使用非侵入性呼吸辅助来促进支气管纤维镜检查的效果——研究方案。
目的:支气管镜检查(FOB)是一种常规检查方法,用于治疗癌症、阻塞、间质性疾病、异物清除、气道清除和咳血。它会导致急性气道狭窄,导致呼吸和心血管压力。由于呼吸衰竭(RF)患者的数量不断增加,传统的氧气治疗(COT)通常不足以确保准确的氧合并防止需要FOB的患者出现RF。在这种临床情况下,患者可以插管并接受有创机械通气(IMV)支持,其具体目的是实现安全的FOB。然而,这种侵入性策略与IMV相关并发症的风险增加有关。材料和方法:我们的研究是一项有计划的前瞻性多中心三组随机对照试验(RCT)。300名患者的目标人数是根据射频患者的插管风险计算的,即0.2-2%。患者将根据Horowitz指数分配到每个手臂。在每只手臂中,患者将被随机分配到每组两种专用呼吸支持方法中的一种,即COT/高流量鼻插管(HFNC)、HFNC/无创通气(NIV)和NIV/IMV。在手稿中讨论了呼吸支持领域的当前技术状态。我们强调了医学证据中的知识差距,我们计划在研究结果中揭示这些差距。结果:我们的研究结果在临床上至关重要,因为它们解决了目前有关COT/HFNC/NIV/IMV的空白。结论:本研究的预期结果将允许仔细选择呼吸支持方法,以安全地对低氧性RF患者进行FOB。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in medical sciences
Advances in medical sciences 医学-医学:研究与实验
CiteScore
5.00
自引率
0.00%
发文量
53
审稿时长
25 days
期刊介绍: Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and molecular Biology, Haematology, Biochemistry, Clinical and Experimental Pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信